Malignant Histiocytic and Dendritic Cell Neoplasm

Malignant Histiocytic and Dendritic Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

82 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 43
Recruiting: 21
Ph III recruiting: 1
Growth YoY: —
Industry share: 14%
Top sponsor: Fred Hutchinson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–12 of 12 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04216524	Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm	recruiting	Phase 2	40	M.D. Anderson Cancer CenterOTHER	1	Sep 14, 2026	clinicaltrials
NCT07749365	Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCL	recruiting	Phase 2	53	The First Affiliated Hospital of Xiamen UniversityOTHER	1	Aug 6, 2026	clinicaltrials